Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bria-IMT by BriaCell Therapeutics for Metastatic Breast Cancer: Likelihood of Approval
"Bria-IMT is under clinical development by BriaCell Therapeutics and currently in Phase III for Metastatic Breast Cancer. According to GlobalData,...